Abstract
Introduction
Recent evidence suggests that there is clear association between microbiota and cognitive functioning, which is known as microbiome-gut-brain axis. Probiotic bacteria consumption can alter human microbiota; therefore, probiotic supplementation might affect the gut microbiota dynamics and influence cognitive function.
Methods
Three electronic databases including PubMed, ProQuest, and EBSCOHost databases were utilized. Manual hand search of article was also done. We selected randomized controlled trial articles that measure cognitive function (as the primary outcome) after intervention with probiotic supplementation on older adult population with AD, MCI, or healthy condition. The following terms and its variant were used: “probiotic,” “cognitive function,” “mild cognitive impairment,” “dementia,” and “Alzheimer’s disease.”
Result
Nine of 10 included studies (AD, MCI, or healthy cognition population) showed cognitive function was improved significantly after probiotic supplementation, compared to control group. One study that included severe AD did not show significant changes.
Conclusion
Most studies involving AD, MCI, or healthy older adults showed cognitive improvement in subjects treated with probiotics for 12–24 weeks.
Similar content being viewed by others
References
Białecka-Dębek A, Granda D, Szmidt MK, Zielińska D (2021) Gut microbiota, probiotic interventions, and cognitive function in the elderly: a review of current knowledge. Nutrition 13(8):2514
Amemori T, Jendelova P, Ruzicka J, Urdzikova LM, Sykova E (2015) Alzheimer’s disease: mechanism and approach to cell therapy. Int J Mol Sci 16(11):26417–26451
Akbari E, Asemi Z, Kakhaki RD, Bahmani F, Kouchaki E, Tamtaji OR, et al. (2016) Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: a randomized, double-blind and controlled trial. Front Aging Neurosci 8(NOV):256
Kim CS, Cha L, Sim M, Jung S, Chun WY, Baik HW et al (2021) Probiotic supplementation improves cognitive function and mood with changes in gut microbiota in community-dwelling older adults: a randomized, double-blind, placebo-controlled, multicenter trial. J Gerontol Ser A 76(1):32–40
Salazar N, Arboleya S, Valdés L, Stanton C, Ross P, Ruiz L, et al. (2014) The human intestinal microbiome at extreme ages of life. Dietary intervention as a way to counteract alterations. Front Genet 5(NOV):406
Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M et al (2012) Human gut microbiome viewed across age and geography. Nature 486(7402):222–227
Cryan JF, O’riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M et al (2019) The microbiota-gut-brain axis. Physiol Rev 99(4):1877–2013
Adams AA, Breathnach CC, Katepalli MP, Kohler K, Horohov DW (2008) Advanced age in horses affects divisional history of T cells and inflammatory cytokine production. Mech Ageing Dev 129(11):656–64
Boren E, Gershwin ME (2004) Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev 3(5):401–406
Sharon G, Sampson TR, Geschwind DH, Mazmanian SK (2016) The central nervous system and the gut microbiome. Cell 167(4):915–932
Sandhu KV, Sherwin E, Schellekens H, Stanton C, Dinan TG, Cryan JF (2017) Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry. Transl Res 179:223–244
Rudzki L, Ostrowska L, Pawlak D, Małus A, Pawlak K, Waszkiewicz N et al (2019) Probiotic Lactobacillus plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: a double-blind, randomized, placebo controlled study. Psychoneuroendocrinology 100:213–222
Tamtaji OR, Heidari-soureshjani R, Mirhosseini N, Kouchaki E, Bahmani F, Aghadavod E et al (2019) Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer’s disease: a randomized, double-blind, controlled trial. Clin Nutr 38(6):2569–2575
Agahi A, Hamidi GA, Daneshvar R, Hamdieh M, Soheili M, Alinaghipour A, et al. (2018) Does severity of Alzheimer’s disease contribute to its responsiveness to modifying gut microbiota? A double blind clinical trial. Front Neurol 9(AUG):662.
Hwang YH, Park S, Paik JW, Chae SW, Kim DH, Jeong DG et al (2019) Efficacy and safety of Lactobacillus plantarum C29-fermented soybean (DW2009) in individuals with mild cognitive impairment: a 12-week, multi-center, randomized, double-blind, placebo-controlled clinical trial. Nutrition 11(2):305
Xiao J, Katsumata N, Bernier F, Ohno K, Yamauchi Y, Odamaki T et al (2020) Probiotic Bifidobacterium breve in improving cognitive functions of older adults with suspected mild cognitive impairment: a randomized, double-blind, placebo-controlled trial. J Alzheimer’s Dis 77(1):139–147
Kobayashi Y, Kuhara T, Oki M, Xiao JZ (2019) Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: a randomised, double-blind, placebo-controlled trial. Benef Microbes 10(5):511–520
Handajani YS, Turana Y, Yogiara Y, Sugiyono SP, Lamadong V, Widjaja NT, et al. (2022) Effects of tempeh probiotics on elderly with cognitive impairment. Front Aging Neurosci 0:645
Chung YC, Jin HM, Cui Y, Kim DS, Jung JM, Park J Il, et al. (2014) Fermented milk of Lactobacillus helveticus IDCC3801 improves cognitive functioning during cognitive fatigue tests in healthy older adults. J Funct Foods 10:465–74
Inoue T, Kobayashi Y, Mori N, Sakagawa M, Xiao JZ, Moritani T et al (2018) Effect of combined bifidobacteria supplementation and resistance training on cognitive function, body composition and bowel habits of healthy elderly subjects. Benef Microbes 9(6):843–853
Kobayashi Y, Kinoshita T, Matsumoto A, Yoshino K, Saito I, Xiao JZ (2018) Bifidobacterium Breve A1 supplementation improved cognitive decline in older adults with mild cognitive impairment: an open-label, single-arm study. J Prev Alzheimer’s Dis 6(1):70–75
Leblhuber F, Egger M, Schuetz B, Fuchs D. (2018) Commentary: effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: a randomized, double-blind and controlled trial. Front Aging Neurosci 10(MAR):54
Zhang ZH, Wen L, Wu QY, Chen C, Zheng R, Liu Q et al (2017) Long-term dietary supplementation with selenium-enriched yeast improves cognitive impairment, reverses synaptic deficits, and mitigates tau pathology in a triple transgenic mouse model of Alzheimer’s Disease. J Agric Food Chem 65(24):4970–4979
Uttara B, Singh A, Zamboni P, Mahajan R (2009) Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 7(1):65–74
Kowalski K, Mulak A (2019) Brain-gut-microbiota axis in Alzheimer’s Disease. J Neurogastroenterol Motil 25(1):48
Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A (2019) Mechanisms of action of probiotics. Adv Nutr 10:S49-66
Genedi M, Janmaat IE, Haarman BCM, Sommer IEC (2019) Dysregulation of the gut-brain axis in schizophrenia and bipolar disorder: probiotic supplementation as a supportive treatment in psychiatric disorders. Curr Opin Psychiatry 32(3):185–195
Wang Y, Li N, Yang JJ, Zhao DM, Chen B, Zhang GQ et al (2020) Probiotics and fructo-oligosaccharide intervention modulate the microbiota-gut brain axis to improve autism spectrum reducing also the hyper-serotonergic state and the dopamine metabolism disorder. Pharmacol Res 157:104784
Yang X, Yu D, Xue L, Li H, Du J (2020) Probiotics modulate the microbiota–gut–brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharm Sin B 10(3):475–487
Musa NH, Mani V, Lim SM, Vidyadaran S, Abdul Majeed AB, Ramasamy K (2017) Lactobacilli-fermented cow’s milk attenuated lipopolysaccharide-induced neuroinflammation and memory impairment in vitro and in vivo. J Dairy Res 84(4):488–495
De-Paula VJR, Forlenza AS, Forlenza OV (2018) Relevance of gutmicrobiota in cognition, behaviour and Alzheimer’s disease. Pharmacol Res 136:29–34
Acknowledgements
We thank Center of Health Research, Atma Jaya Catholic University of Indonesia colleagues for their endless support and help.
Author information
Authors and Affiliations
Contributions
Conceptualization: Yvonne Suzy Handajani and Antoninus Hengky; methodology: Antoninus Hengky; literature search, formal analysis, and investigation: Antoninus Hengky; writing — original draft preparation: Yvonne Suzy Handajani and Antoninus Hengky; writing — review and editing: Eef Hogervorst, Elisabeth Schroeder-Butterfill, and Yuda Turana; supervision: Yvonne Suzy Handajani, Eef Hogervorst, and Yuda Turana.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Handajani, Y.S., Hengky, A., Schröder-Butterfill, E. et al. Probiotic supplementation improved cognitive function in cognitively impaired and healthy older adults: a systematic review of recent trials. Neurol Sci 44, 1163–1169 (2023). https://doi.org/10.1007/s10072-022-06540-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-022-06540-8